nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—CYP3A4—Pilocarpine—glaucoma	0.121	0.236	CbGbCtD
Methyltestosterone—CYP3A4—Brinzolamide—glaucoma	0.0952	0.185	CbGbCtD
Methyltestosterone—CYP3A4—Dorzolamide—glaucoma	0.0919	0.178	CbGbCtD
Methyltestosterone—CYP3A4—Methazolamide—glaucoma	0.0819	0.159	CbGbCtD
Methyltestosterone—CYP3A4—Acetazolamide—glaucoma	0.0655	0.127	CbGbCtD
Methyltestosterone—CYP3A4—Clonidine—glaucoma	0.0592	0.115	CbGbCtD
Methyltestosterone—Hirsutism—Bimatoprost—glaucoma	0.0205	0.0527	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Acetazolamide—glaucoma	0.0125	0.0322	CcSEcCtD
Methyltestosterone—Libido decreased—Apraclonidine—glaucoma	0.00963	0.0247	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Apraclonidine—glaucoma	0.00886	0.0228	CcSEcCtD
Methyltestosterone—Nausea—Physostigmine—glaucoma	0.00841	0.0216	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Acetazolamide—glaucoma	0.00825	0.0212	CcSEcCtD
Methyltestosterone—Libido decreased—Dorzolamide—glaucoma	0.0079	0.0203	CcSEcCtD
Methyltestosterone—Libido decreased—Brinzolamide—glaucoma	0.00776	0.0199	CcSEcCtD
Methyltestosterone—Alopecia—Levobunolol—glaucoma	0.00736	0.0189	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Dorzolamide—glaucoma	0.00726	0.0187	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Brinzolamide—glaucoma	0.00714	0.0183	CcSEcCtD
Methyltestosterone—Anxiety—Metipranolol—glaucoma	0.00703	0.0181	CcSEcCtD
Methyltestosterone—Gynaecomastia—Clonidine—glaucoma	0.00681	0.0175	CcSEcCtD
Methyltestosterone—Haemorrhage—Apraclonidine—glaucoma	0.00618	0.0159	CcSEcCtD
Methyltestosterone—Libido decreased—Clonidine—glaucoma	0.00596	0.0153	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Methazolamide—glaucoma	0.00567	0.0146	CcSEcCtD
Methyltestosterone—Angiopathy—Apraclonidine—glaucoma	0.00561	0.0144	CcSEcCtD
Methyltestosterone—Paraesthesia—Diclofenamide—glaucoma	0.00553	0.0142	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Clonidine—glaucoma	0.00548	0.0141	CcSEcCtD
Methyltestosterone—Angiopathy—Bimatoprost—glaucoma	0.00543	0.014	CcSEcCtD
Methyltestosterone—Paraesthesia—Levobunolol—glaucoma	0.00532	0.0137	CcSEcCtD
Methyltestosterone—Libido decreased—Betaxolol—glaucoma	0.00519	0.0133	CcSEcCtD
Methyltestosterone—Paraesthesia—Methazolamide—glaucoma	0.00509	0.0131	CcSEcCtD
Methyltestosterone—Angiopathy—Brimonidine—glaucoma	0.00481	0.0124	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Betaxolol—glaucoma	0.00477	0.0123	CcSEcCtD
Methyltestosterone—Angiopathy—Travoprost—glaucoma	0.00458	0.0118	CcSEcCtD
Methyltestosterone—Angiopathy—Brinzolamide—glaucoma	0.00452	0.0116	CcSEcCtD
Methyltestosterone—Alopecia—Dorzolamide—glaucoma	0.00448	0.0115	CcSEcCtD
Methyltestosterone—Anxiety—Bimatoprost—glaucoma	0.00442	0.0114	CcSEcCtD
Methyltestosterone—Alopecia—Brinzolamide—glaucoma	0.0044	0.0113	CcSEcCtD
Methyltestosterone—Libido decreased—Timolol—glaucoma	0.00424	0.0109	CcSEcCtD
Methyltestosterone—Headache—Metipranolol—glaucoma	0.00424	0.0109	CcSEcCtD
Methyltestosterone—Alopecia—Pilocarpine—glaucoma	0.00423	0.0109	CcSEcCtD
Methyltestosterone—Nausea—Metipranolol—glaucoma	0.00402	0.0103	CcSEcCtD
Methyltestosterone—Paraesthesia—Apraclonidine—glaucoma	0.00394	0.0101	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Acetazolamide—glaucoma	0.00393	0.0101	CcSEcCtD
Methyltestosterone—Headache—Carteolol—glaucoma	0.00393	0.0101	CcSEcCtD
Methyltestosterone—Anxiety—Brimonidine—glaucoma	0.00392	0.0101	CcSEcCtD
Methyltestosterone—Disturbance in sexual arousal—Timolol—glaucoma	0.0039	0.01	CcSEcCtD
Methyltestosterone—Headache—Diclofenamide—glaucoma	0.00386	0.00991	CcSEcCtD
Methyltestosterone—Headache—Carbachol—glaucoma	0.00377	0.00968	CcSEcCtD
Methyltestosterone—Anxiety—Dorzolamide—glaucoma	0.00374	0.00961	CcSEcCtD
Methyltestosterone—Anxiety—Travoprost—glaucoma	0.00372	0.00957	CcSEcCtD
Methyltestosterone—Nausea—Carteolol—glaucoma	0.00372	0.00956	CcSEcCtD
Methyltestosterone—Headache—Levobunolol—glaucoma	0.00371	0.00953	CcSEcCtD
Methyltestosterone—Nausea—Diclofenamide—glaucoma	0.00366	0.0094	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Dorzolamide—glaucoma	0.0036	0.00924	CcSEcCtD
Methyltestosterone—Nausea—Carbachol—glaucoma	0.00357	0.00917	CcSEcCtD
Methyltestosterone—Loteprednol—NR3C1—glaucoma	0.00357	0.106	CrCbGaD
Methyltestosterone—Headache—Methazolamide—glaucoma	0.00355	0.00913	CcSEcCtD
Methyltestosterone—Anxiety—Pilocarpine—glaucoma	0.00353	0.00908	CcSEcCtD
Methyltestosterone—Paraesthesia—Acetazolamide—glaucoma	0.00353	0.00906	CcSEcCtD
Methyltestosterone—Nausea—Levobunolol—glaucoma	0.00352	0.00903	CcSEcCtD
Methyltestosterone—Angiopathy—Clonidine—glaucoma	0.00347	0.00891	CcSEcCtD
Methyltestosterone—Headache—Latanoprost—glaucoma	0.00344	0.00884	CcSEcCtD
Methyltestosterone—Paraesthesia—Brimonidine—glaucoma	0.00338	0.00869	CcSEcCtD
Methyltestosterone—Alopecia—Clonidine—glaucoma	0.00338	0.00868	CcSEcCtD
Methyltestosterone—Nausea—Methazolamide—glaucoma	0.00337	0.00865	CcSEcCtD
Methyltestosterone—Medrysone—NR3C1—glaucoma	0.00328	0.0972	CrCbGaD
Methyltestosterone—Paraesthesia—Dorzolamide—glaucoma	0.00323	0.0083	CcSEcCtD
Methyltestosterone—Paraesthesia—Brinzolamide—glaucoma	0.00318	0.00816	CcSEcCtD
Methyltestosterone—Hydrocortamate—NR3C1—glaucoma	0.00306	0.0906	CrCbGaD
Methyltestosterone—Paraesthesia—Pilocarpine—glaucoma	0.00305	0.00784	CcSEcCtD
Methyltestosterone—Angiopathy—Betaxolol—glaucoma	0.00302	0.00776	CcSEcCtD
Methyltestosterone—Cortisone acetate—NR3C1—glaucoma	0.00301	0.0892	CrCbGaD
Methyltestosterone—Alopecia—Betaxolol—glaucoma	0.00294	0.00755	CcSEcCtD
Methyltestosterone—Megestrol acetate—NR3C1—glaucoma	0.0029	0.086	CrCbGaD
Methyltestosterone—Anxiety—Clonidine—glaucoma	0.00282	0.00725	CcSEcCtD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—PITX2—glaucoma	0.00277	0.0446	CbGpPWpGaD
Methyltestosterone—Headache—Apraclonidine—glaucoma	0.00275	0.00706	CcSEcCtD
Methyltestosterone—Headache—Bimatoprost—glaucoma	0.00267	0.00685	CcSEcCtD
Methyltestosterone—Nausea—Apraclonidine—glaucoma	0.00261	0.0067	CcSEcCtD
Methyltestosterone—Nausea—Bimatoprost—glaucoma	0.00253	0.00649	CcSEcCtD
Methyltestosterone—Angiopathy—Timolol—glaucoma	0.00247	0.00634	CcSEcCtD
Methyltestosterone—Headache—Acetazolamide—glaucoma	0.00246	0.00632	CcSEcCtD
Methyltestosterone—Anxiety—Betaxolol—glaucoma	0.00246	0.00631	CcSEcCtD
Methyltestosterone—Paraesthesia—Clonidine—glaucoma	0.00244	0.00626	CcSEcCtD
Methyltestosterone—Alopecia—Timolol—glaucoma	0.0024	0.00617	CcSEcCtD
Methyltestosterone—Fludrocortisone—NR3C1—glaucoma	0.00239	0.0707	CrCbGaD
Methyltestosterone—Headache—Brimonidine—glaucoma	0.00236	0.00606	CcSEcCtD
Methyltestosterone—Nausea—Acetazolamide—glaucoma	0.00233	0.00599	CcSEcCtD
Methyltestosterone—Headache—Dorzolamide—glaucoma	0.00225	0.00579	CcSEcCtD
Methyltestosterone—Headache—Travoprost—glaucoma	0.00224	0.00577	CcSEcCtD
Methyltestosterone—Nausea—Brimonidine—glaucoma	0.00224	0.00575	CcSEcCtD
Methyltestosterone—Headache—Brinzolamide—glaucoma	0.00222	0.00569	CcSEcCtD
Methyltestosterone—Nausea—Dorzolamide—glaucoma	0.00214	0.00549	CcSEcCtD
Methyltestosterone—Headache—Pilocarpine—glaucoma	0.00213	0.00547	CcSEcCtD
Methyltestosterone—Nausea—Travoprost—glaucoma	0.00213	0.00547	CcSEcCtD
Methyltestosterone—Paraesthesia—Betaxolol—glaucoma	0.00212	0.00545	CcSEcCtD
Methyltestosterone—Nausea—Brinzolamide—glaucoma	0.0021	0.0054	CcSEcCtD
Methyltestosterone—Nausea—Pilocarpine—glaucoma	0.00202	0.00519	CcSEcCtD
Methyltestosterone—Anxiety—Timolol—glaucoma	0.00201	0.00516	CcSEcCtD
Methyltestosterone—Fluoxymesterone—NR3C1—glaucoma	0.00197	0.0584	CrCbGaD
Methyltestosterone—Anaphylactic shock—Timolol—glaucoma	0.00193	0.00496	CcSEcCtD
Methyltestosterone—Spironolactone—NR3C1—glaucoma	0.00181	0.0535	CrCbGaD
Methyltestosterone—Paraesthesia—Timolol—glaucoma	0.00173	0.00446	CcSEcCtD
Methyltestosterone—Prednisone—NR3C1—glaucoma	0.0017	0.0504	CrCbGaD
Methyltestosterone—Headache—Clonidine—glaucoma	0.0017	0.00437	CcSEcCtD
Methyltestosterone—Medroxyprogesterone Acetate—NR3C1—glaucoma	0.00169	0.0501	CrCbGaD
Methyltestosterone—Progesterone—CYP1B1—glaucoma	0.00164	0.0487	CrCbGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00162	0.0262	CbGpPWpGaD
Methyltestosterone—Nausea—Clonidine—glaucoma	0.00161	0.00414	CcSEcCtD
Methyltestosterone—Prednisolone—NR3C1—glaucoma	0.00157	0.0464	CrCbGaD
Methyltestosterone—Testosterone—CYP1B1—glaucoma	0.00155	0.046	CrCbGaD
Methyltestosterone—Headache—Betaxolol—glaucoma	0.00148	0.0038	CcSEcCtD
Methyltestosterone—CYP19A1—Endogenous sterols—CYP1B1—glaucoma	0.00148	0.0238	CbGpPWpGaD
Methyltestosterone—Drospirenone—PTGS2—glaucoma	0.00144	0.0426	CrCbGaD
Methyltestosterone—Nausea—Betaxolol—glaucoma	0.0014	0.00361	CcSEcCtD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00138	0.0222	CbGpPWpGaD
Methyltestosterone—Headache—Timolol—glaucoma	0.00121	0.00311	CcSEcCtD
Methyltestosterone—Hydrocortisone—NR3C1—glaucoma	0.0012	0.0355	CrCbGaD
Methyltestosterone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.00115	0.0185	CbGpPWpGaD
Methyltestosterone—Nausea—Timolol—glaucoma	0.00115	0.00295	CcSEcCtD
Methyltestosterone—ALB—HDL-mediated lipid transport—ABCA1—glaucoma	0.00112	0.0181	CbGpPWpGaD
Methyltestosterone—CYP19A1—FSH signaling pathway—BDNF—glaucoma	0.00109	0.0175	CbGpPWpGaD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—CCND2—glaucoma	0.00107	0.0172	CbGpPWpGaD
Methyltestosterone—Progesterone—NR3C1—glaucoma	0.000977	0.0289	CrCbGaD
Methyltestosterone—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000914	0.0147	CbGpPWpGaD
Methyltestosterone—AR—FOXA1 transcription factor network—SOD1—glaucoma	0.000911	0.0147	CbGpPWpGaD
Methyltestosterone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000893	0.0144	CbGpPWpGaD
Methyltestosterone—AR—Nuclear Receptors—NR3C1—glaucoma	0.00085	0.0137	CbGpPWpGaD
Methyltestosterone—CYP19A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000849	0.0137	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.00084	0.0135	CbGpPWpGaD
Methyltestosterone—SLC22A8—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000782	0.0126	CbGpPWpGaD
Methyltestosterone—ALB—HDL-mediated lipid transport—APOE—glaucoma	0.00074	0.0119	CbGpPWpGaD
Methyltestosterone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000694	0.0112	CbGpPWpGaD
Methyltestosterone—SLCO1A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000694	0.0112	CbGpPWpGaD
Methyltestosterone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000686	0.0111	CbGpPWpGaD
Methyltestosterone—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000677	0.0109	CbGpPWpGaD
Methyltestosterone—AR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000672	0.0108	CbGpPWpGaD
Methyltestosterone—AR—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000652	0.0105	CbGpPWpGaD
Methyltestosterone—ALB—Lipoprotein metabolism—ABCA1—glaucoma	0.000646	0.0104	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—glaucoma	0.000596	0.0096	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—PEX19—glaucoma	0.000588	0.00947	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000582	0.00938	CbGpPWpGaD
Methyltestosterone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000556	0.00896	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000529	0.00852	CbGpPWpGaD
Methyltestosterone—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000525	0.00845	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000522	0.00841	CbGpPWpGaD
Methyltestosterone—SLC22A8—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000522	0.0084	CbGpPWpGaD
Methyltestosterone—CYP19A1—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000484	0.0078	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000464	0.00747	CbGpPWpGaD
Methyltestosterone—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000464	0.00747	CbGpPWpGaD
Methyltestosterone—SLCO1A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000463	0.00746	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—TXN—glaucoma	0.000442	0.00712	CbGpPWpGaD
Methyltestosterone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000441	0.0071	CbGpPWpGaD
Methyltestosterone—AR—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000436	0.00703	CbGpPWpGaD
Methyltestosterone—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000435	0.00701	CbGpPWpGaD
Methyltestosterone—ALB—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.000429	0.00691	CbGpPWpGaD
Methyltestosterone—ALB—Lipoprotein metabolism—APOE—glaucoma	0.000425	0.00684	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—ABCA1—glaucoma	0.000423	0.00681	CbGpPWpGaD
Methyltestosterone—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.00042	0.00676	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000417	0.00671	CbGpPWpGaD
Methyltestosterone—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.000414	0.00667	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000397	0.0064	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000388	0.00624	CbGpPWpGaD
Methyltestosterone—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000382	0.00615	CbGpPWpGaD
Methyltestosterone—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	0.000379	0.00611	CbGpPWpGaD
Methyltestosterone—AR—Androgen receptor signaling pathway—CAV1—glaucoma	0.000379	0.00611	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—SOD1—glaucoma	0.000377	0.00607	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—GSTT1—glaucoma	0.000371	0.00597	CbGpPWpGaD
Methyltestosterone—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000357	0.00575	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000353	0.00568	CbGpPWpGaD
Methyltestosterone—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—glaucoma	0.000352	0.00567	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—TGFB2—glaucoma	0.000347	0.00558	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—ABCA1—glaucoma	0.000344	0.00554	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000339	0.00546	CbGpPWpGaD
Methyltestosterone—SLCO1A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000339	0.00546	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.000333	0.00537	CbGpPWpGaD
Methyltestosterone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—glaucoma	0.000331	0.00533	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.00033	0.00532	CbGpPWpGaD
Methyltestosterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000316	0.00508	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000311	0.00501	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—SOD1—glaucoma	0.000306	0.00494	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000306	0.00492	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.000305	0.00492	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000299	0.00481	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—MTHFR—glaucoma	0.000299	0.00481	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—CYP1B1—glaucoma	0.000296	0.00476	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000292	0.00469	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000289	0.00465	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CA5A—glaucoma	0.000288	0.00463	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NARFL—glaucoma	0.000288	0.00463	CbGpPWpGaD
Methyltestosterone—ALB—Lipid and lipoprotein metabolism—APOE—glaucoma	0.000282	0.00455	CbGpPWpGaD
Methyltestosterone—ALB—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.00028	0.00451	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—APOE—glaucoma	0.000278	0.00448	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000276	0.00445	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—NGF—glaucoma	0.000276	0.00445	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000275	0.00442	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—ABCA1—glaucoma	0.000273	0.0044	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000266	0.00429	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000265	0.00427	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000265	0.00426	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—SOD1—glaucoma	0.000263	0.00423	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CA5A—glaucoma	0.00026	0.00419	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NARFL—glaucoma	0.00026	0.00419	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000259	0.00417	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—PEX19—glaucoma	0.000255	0.00411	CbGpPWpGaD
Methyltestosterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	0.000251	0.00403	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.00025	0.00403	CbGpPWpGaD
Methyltestosterone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000248	0.00399	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—SOD1—glaucoma	0.000243	0.00392	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—MTHFR—glaucoma	0.000243	0.00391	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—GSTT1—glaucoma	0.000238	0.00384	CbGpPWpGaD
Methyltestosterone—CYP19A1—Biological oxidations—GSTM1—glaucoma	0.000236	0.00381	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000235	0.00379	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000234	0.00376	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	0.000233	0.00375	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000226	0.00365	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000226	0.00364	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000223	0.00359	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000201	0.00324	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.0002	0.00323	CbGpPWpGaD
Methyltestosterone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000198	0.00318	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000194	0.00312	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000194	0.00312	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	0.000193	0.00311	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—CYP1B1—glaucoma	0.00019	0.00306	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	0.000187	0.00301	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—FN1—glaucoma	0.000183	0.00294	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000174	0.00281	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000172	0.00278	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000172	0.00277	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CA5A—glaucoma	0.000167	0.00269	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NARFL—glaucoma	0.000167	0.00269	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000166	0.00267	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000162	0.00262	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000154	0.00248	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—GSTM1—glaucoma	0.000152	0.00244	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	0.00015	0.00241	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000149	0.0024	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000142	0.00229	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CA5A—glaucoma	0.000141	0.00226	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NARFL—glaucoma	0.000141	0.00226	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CA1—glaucoma	0.00014	0.00226	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CTSA—glaucoma	0.000136	0.00219	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000135	0.00218	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000135	0.00217	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000132	0.00213	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000132	0.00212	CbGpPWpGaD
Methyltestosterone—ALB—Vitamin B12 Metabolism—TNF—glaucoma	0.000129	0.00207	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CA2—glaucoma	0.000128	0.00207	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CA1—glaucoma	0.000127	0.00204	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000126	0.00202	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000126	0.00202	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	0.000123	0.00198	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CTSA—glaucoma	0.000123	0.00198	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000117	0.00188	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000116	0.00188	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CA2—glaucoma	0.000116	0.00187	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—NR3C1—glaucoma	0.000116	0.00187	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000115	0.00185	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000114	0.00183	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000114	0.00183	CbGpPWpGaD
Methyltestosterone—AR—SIDS Susceptibility Pathways—TNF—glaucoma	0.000113	0.00182	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000112	0.00181	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000108	0.00174	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFA—glaucoma	0.000105	0.00169	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TNF—glaucoma	0.000105	0.00168	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000102	0.00165	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	9.97e-05	0.00161	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	9.61e-05	0.00155	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—glaucoma	9.22e-05	0.00149	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—TXN—glaucoma	9.05e-05	0.00146	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	8.8e-05	0.00142	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	8.63e-05	0.00139	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	8.51e-05	0.00137	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	8.47e-05	0.00136	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.42e-05	0.00136	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—TNF—glaucoma	8.31e-05	0.00134	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.26e-05	0.00133	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.18e-05	0.00132	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—TXN—glaucoma	8.18e-05	0.00132	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CA1—glaucoma	8.15e-05	0.00131	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	8.11e-05	0.00131	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TGFB2—glaucoma	7.93e-05	0.00128	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CTSA—glaucoma	7.9e-05	0.00127	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NARFL—glaucoma	7.59e-05	0.00122	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CA5A—glaucoma	7.59e-05	0.00122	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.47e-05	0.0012	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CA2—glaucoma	7.46e-05	0.0012	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.4e-05	0.00119	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTT1—glaucoma	7.02e-05	0.00113	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTM1—glaucoma	6.9e-05	0.00111	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CA1—glaucoma	6.86e-05	0.00111	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	6.8e-05	0.0011	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CTSA—glaucoma	6.65e-05	0.00107	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—CDKN2B—glaucoma	6.37e-05	0.00103	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTT1—glaucoma	6.34e-05	0.00102	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CA2—glaucoma	6.28e-05	0.00101	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.14e-05	0.000988	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.14e-05	0.000988	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—SOD1—glaucoma	6.01e-05	0.000967	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.66e-05	0.000912	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ABCA1—glaucoma	5.59e-05	0.000901	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP1B1—glaucoma	5.59e-05	0.000901	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—NR3C1—glaucoma	5.59e-05	0.0009	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—TXN—glaucoma	5.25e-05	0.000846	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.12e-05	0.000824	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP1B1—glaucoma	5.05e-05	0.000814	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ABCA1—glaucoma	5.05e-05	0.000814	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	4.64e-05	0.000748	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—MMP1—glaucoma	4.58e-05	0.000738	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTM1—glaucoma	4.47e-05	0.00072	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—TXN—glaucoma	4.42e-05	0.000712	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—CAV1—glaucoma	4.39e-05	0.000707	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—FN1—glaucoma	4.18e-05	0.000673	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTT1—glaucoma	4.07e-05	0.000656	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTM1—glaucoma	4.04e-05	0.000651	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.04e-05	0.00065	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4e-05	0.000644	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—MTHFR—glaucoma	3.95e-05	0.000636	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CA1—glaucoma	3.71e-05	0.000597	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—APOE—glaucoma	3.68e-05	0.000592	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CAV1—glaucoma	3.64e-05	0.000587	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CTSA—glaucoma	3.59e-05	0.000578	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—MTHFR—glaucoma	3.57e-05	0.000575	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTT1—glaucoma	3.43e-05	0.000552	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CA2—glaucoma	3.39e-05	0.000546	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—APOE—glaucoma	3.32e-05	0.000535	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—NOS3—glaucoma	3.32e-05	0.000535	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CAV1—glaucoma	3.29e-05	0.000531	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ABCA1—glaucoma	3.25e-05	0.000523	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP1B1—glaucoma	3.25e-05	0.000523	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.77e-05	0.000445	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—NOS3—glaucoma	2.76e-05	0.000444	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP1B1—glaucoma	2.73e-05	0.00044	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ABCA1—glaucoma	2.73e-05	0.00044	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTM1—glaucoma	2.6e-05	0.000418	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTGS2—glaucoma	2.52e-05	0.000406	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—NOS3—glaucoma	2.49e-05	0.000401	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—glaucoma	2.39e-05	0.000385	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—TXN—glaucoma	2.39e-05	0.000385	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—MTHFR—glaucoma	2.29e-05	0.000369	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTGS2—glaucoma	2.28e-05	0.000367	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTM1—glaucoma	2.18e-05	0.000352	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—APOE—glaucoma	2.14e-05	0.000344	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CAV1—glaucoma	2.12e-05	0.000341	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—MTHFR—glaucoma	1.93e-05	0.000311	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTT1—glaucoma	1.85e-05	0.000298	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—glaucoma	1.81e-05	0.000291	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—APOE—glaucoma	1.8e-05	0.000289	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CAV1—glaucoma	1.78e-05	0.000287	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—NOS3—glaucoma	1.6e-05	0.000258	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP1B1—glaucoma	1.48e-05	0.000238	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ABCA1—glaucoma	1.48e-05	0.000238	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTGS2—glaucoma	1.46e-05	0.000236	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—NOS3—glaucoma	1.35e-05	0.000217	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTGS2—glaucoma	1.23e-05	0.000198	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTM1—glaucoma	1.18e-05	0.00019	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—MTHFR—glaucoma	1.04e-05	0.000168	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—APOE—glaucoma	9.7e-06	0.000156	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CAV1—glaucoma	9.61e-06	0.000155	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—NOS3—glaucoma	7.27e-06	0.000117	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTGS2—glaucoma	6.65e-06	0.000107	CbGpPWpGaD
